These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24533717)

  • 1. Priority pharmacogenetics for the African continent: focus on CYP450.
    Alessandrini M; Pepper MS
    Pharmacogenomics; 2014 Feb; 15(3):385-400. PubMed ID: 24533717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 pharmacogenetics in African populations.
    Alessandrini M; Asfaha S; Dodgen TM; Warnich L; Pepper MS
    Drug Metab Rev; 2013 May; 45(2):253-75. PubMed ID: 23590174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.
    Rajman I; Knapp L; Morgan T; Masimirembwa C
    EBioMedicine; 2017 Mar; 17():67-74. PubMed ID: 28237373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice.
    Pilotto A; Panza F; Seripa D
    Curr Drug Metab; 2011 Sep; 12(7):621-34. PubMed ID: 21495974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.
    Čolić A; Alessandrini M; Pepper MS
    Drug Metab Rev; 2015 May; 47(2):111-23. PubMed ID: 25391641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
    van Schaik RH
    Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics in HIV therapy.
    Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
    AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of pharmacogenetics to pharmacovigilance.
    Bondon-Guitton E; Despas F; Becquemont L
    Therapie; 2016 Apr; 71(2):223-8. PubMed ID: 27080842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics approach to therapeutics.
    Koo SH; Lee EJ
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):525-32. PubMed ID: 16700889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of CYP450 enzyme gene polymorphisms in the Greek population: review of the literature, original findings and clinical significance.
    Ragia G; Giannakopoulou E; Karaglani M; Karantza IM; Tavridou A; Manolopoulos VG
    Drug Metabol Drug Interact; 2014; 29(4):235-48. PubMed ID: 24756055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, tuberculosis and malaria in Congolese populations of Central Africa.
    Pallerla SR; Elion Assiana DO; Linh LTK; Cho FN; Meyer CG; Fagbemi KA; Adegnika AA; Beng VP; Achidi EA; Kahunu GM; Bates M; Grobusch MP; Kremsner PG; Ntoumi F; Velavan TP
    Int J Infect Dis; 2021 Mar; 104():207-213. PubMed ID: 33310105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic literacy series: clinical application of pharmacogenetics for adverse reactions to antiepileptic drugs.
    Zhang Z; Wu Y; Tan NC; Jiang Y
    Epileptic Disord; 2019 Aug; 21(4):330-336. PubMed ID: 31403464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Falls: the adverse drug reaction of the elderly and the impact of pharmacogenetics.
    Just KS; Schneider KL; Schurig M; Stingl JC; Brockmöller J
    Pharmacogenomics; 2017 Aug; 18(13):1281-1297. PubMed ID: 28776468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacogenetic study of CD4 recovery in response to HIV antiretroviral therapy in two South African population groups.
    Parathyras J; Gebhardt S; Hillermann-Rebello R; Grobbelaar N; Venter M; Warnich L
    J Hum Genet; 2009 May; 54(5):261-5. PubMed ID: 19282874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADME pharmacogenetics: future outlook for Russia.
    Mirzaev KB; Fedorinov DS; Ivashchenko DV; Sychev DA
    Pharmacogenomics; 2019 Jul; 20(11):847-865. PubMed ID: 31368406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical approach to pharmacogenetics.
    de Graaff LC; van Schaik RH; van Gelder T
    Neth J Med; 2013 Apr; 71(3):145-52. PubMed ID: 23712814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 in Cancer Susceptibility and Treatment.
    Mittal B; Tulsyan S; Kumar S; Mittal RD; Agarwal G
    Adv Clin Chem; 2015; 71():77-139. PubMed ID: 26411412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring pharmacogenetics in special groups: geriatrics.
    Seripa D; Panza F; Daragjati J; Paroni G; Pilotto A
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1073-88. PubMed ID: 25990744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic associations with cytochrome P450 in antiretroviral therapy: what does the future hold?
    Stillemans G; Belkhir L; Hesselink DA; Haufroid V; Elens L
    Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):601-611. PubMed ID: 29775551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.